Yirivinti Hayagreeva Dinakar
Overview
Explore the profile of Yirivinti Hayagreeva Dinakar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dey S, Dinakar Y, R S, Jain V, Jain R
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Oct;
PMID: 39441235
Breast cancer is a common and deadly malignancy that affects women globally, and breast cancer stem cells (BCSCs) play an important role in tumorigenesis, development, metastasis, and recurrence. Traditional therapies...
2.
Sai B, Dinakar Y, Kumar H, Jain R, Kesharwani S, Kesharwani S, et al.
Ther Deliv
. 2024 Sep;
15(11):871-891.
PMID: 39320858
Breast cancer is the leading cause of cancer-related deaths among women globally. The difficulties with anticancer medications, such as ineffective targeting, larger doses, toxicity to healthy cells and side effects,...
3.
Karole A, Dinakar Y, Sagar P, Mudavath S
Nanoscale
. 2024 Mar;
16(15):7453-7466.
PMID: 38517408
Pancreatic cancer is one of the major cause of cancer-related deaths worldwide, and is mainly associated with carcinomas of the pancreatic tissue. Current therapies for treating pancreatic cancer have a...
4.
Dinakar Y, Rajana N, Kumari N, Jain V, Mehra N
AAPS PharmSciTech
. 2023 Dec;
24(8):258.
PMID: 38097825
Even though chemotherapy stands as a standard option in the therapy of TNBC, problems associated with it such as anemia, bone marrow suppression, immune suppression, toxic effects on healthy cells,...
5.
Jain D, Dinakar Y, Kumar H, Jain R, Jain V
Cancer Drug Resist
. 2023 Oct;
6(3):481-498.
PMID: 37842237
Prostate cancer is the second most prominent form of cancer in men and confers the highest mortality after lung cancer. The term "extracellular vesicles" refers to minute endosomal-derived membrane microvesicles...
6.
Dinakar Y, Karole A, Parvez S, Jain V, Mudavath S
Biochim Biophys Acta Gen Subj
. 2023 Jun;
1867(9):130396.
PMID: 37271407
Background: Liposomes are predominantly used sorts of nanocarriers for active a targeted delivery through surface functionalization using targeting ligand. The folate receptors are overexpressed in various cancers including breast cancer...
7.
Dinakar Y, Karole A, Parvez S, Jain V, Mudavath S
Life Sci
. 2022 Oct;
310:121133.
PMID: 36306866
Lung Cancer (LC) is the malignant tumor of the lungs which is defined by the unrestricted cell development in the lung tissues which if left untreated may migrate to different...
8.
Dinakar Y, Kumar H, Mudavath S, Jain R, Ajmeer R, Jain V
Life Sci
. 2022 Sep;
309:120996.
PMID: 36170890
Introduction: Breast cancer (BC) accounts for the majority of cancers among the female population. Anomalous activation of various signaling pathways has become an issue of concern. The JAK-STAT signaling pathway...